✦ LIBER ✦

Mepolizumab, a Humanized Monoclonal Antibody to IL-5, for Severe Eosinophilic Esophagitis in Adults: A Randomized, Placebo-Controlled Double-Blind Trial

✍ Scribed by STRAUMANN, A; CONUS, S; KITA, H; KEPHART, G; BUSSMANN, C; BEGLINGER, C; PATEL, J; BYRNE, M; SIMON, H

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The Pharmacodynamic Effects of Mepolizum

✍ Assa'ad, A.; Aceves, S.; Gupta, S.; Drouin, É.; Collins, M.; Jurgensen, C.; Heat 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Montelukast treatment of moderate to sev

✍ Niels K. Veien; Michael Busch-Sørensen; Birgitte Stausbøl-Grøn 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 88 KB

A randomized, double-blind, placebo-cont

✍ B. G. Feagan; W. J. Sandborn; J. P. Baker; F. Cominelli; L. R. Sutherland; C. O 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 331 KB

Secukinumab, a human anti-IL-17A monoclo

✍ Hueber, W.; Sands, B. E.; Lewitzky, S.; Vandemeulebroecke, M.; Reinisch, W.; Hig 📂 Article 📅 2012 🏛 BMJ Publishing Group 🌐 English ⚖ 304 KB

Treatment of septic shock with human mon

✍ RV McCloskey; RC Straube; C Sanders; SM Smith; CR Smith 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 249 KB

A Double-Blind, Randomized, Placebo-Cont

✍ Aditya K. Gupta; Gideon Koren; Neil H. Shear 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 436 KB